Company Snapshot
Rubrik Inc. | RBRK | NYSE
| Area | Current view |
|---|---|
| Sector | Cybersecurity, data protection and operational recovery |
| Thesis status | Intact and strengthening operationally; valuation requires discipline |
| Conviction | High in results to date; moderately high in the long-term thesis; lower in AI-agent monetization |
| Horizon | 3–5 years |
| Main question | Can Rubrik sustain roughly 25–30% growth and increase per-share value fast enough to justify today's premium? |
| Updated | Review October 12, 2026, partial evidence coverage; results through July 31, 2026; new announcement October 9, 2026; intraday quote October 12, 2026, 10:43 a.m. EDT |
The 30-second view: Rubrik helps organizations recover data, identities and operations after attacks or mistakes. Subscriptions grow, customers buy more products and cash flow is positive. Identity Resilience has measurable traction; AI-agent security is an additional early opportunity. The USD 122.51 intraday quote from October 12, 2026 at 10:43 a.m. EDT nevertheless requires many years of excellent performance.
What matters most
- Subscription ARR USD 1.66 billion, +33%: the clearest subscription scale and growth metric.
- Net new ARR roughly USD 96 million, +35% year over year: accelerating additions, not 35% total ARR growth.
- NRR above 119%: existing cohorts expand spending; the disclosed metric averages four quarterly values.
- FY2027 FCF guidance USD 323–333 million: scaling works; cash flow per share also matters.
- More than 15 paying RAC customers: initial commercial evidence, still a small base for large expectations.
Results and RAC: Q2 FY2027 transcript. NRR definition: July 31, 2026 10-Q. Fiscal year ends January 31: August 2026 results are Q2 FY2027.
Investment Thesis
Rubrik can grow by extending from data recovery into shared protection of data, identities and AI agents. Existing subscriptions and selling more into the same customer base form the foundation; RAC and Annapurna success would add growth.
| Pillar | Evidence | What must continue |
|---|---|---|
| Recovery is critical security infrastructure | 33% ARR growth at USD 1.66 billion scale | Customers fund resilience and Rubrik wins share |
| Platform increases customer spending | NRR above 119%; broader adoption | Cross-selling produces incremental ARR |
| Identity becomes a second growth engine | Above USD 50 million ARR in Q1 FY2027 | Adoption beyond initial large customers |
| Growth improves economics | Better contribution margin and raised FCF guidance | Margins and FCF per share increase after dilution |
Sources: attached Q1 and Q2 transcripts and Analyst Day, June 10, 2026.
Possibly underappreciated: data/identity integration and the economics of another product sold to an existing customer. What price probably assumes: durable growth, more successful products and high future margins. This is valuation interpretation, not measured market expectations.
The Business
Rubrik mainly sells subscription software protecting on-premises data centers, public cloud and SaaS applications. Customers often start with one product and expand as data, applications and security needs grow.
| Offering | Customer benefit | Investment relevance |
|---|---|---|
| Rubrik Security Cloud | Data protection, clean recovery points and recovery orchestration | Established ARR foundation |
| Identity Resilience | Identity recovery and removal of malicious changes while retaining legitimate ones | Fast-growing addition accessing CISO budgets |
| Rubrik Agent Cloud | Agent visibility, access control, runtime guardrails and Agent Rewind | Early market with growth potential |
| Code Guardian | Testing a copy of source code using Claude; still in private preview | Product option without disclosed ARR or revenue |
| Annapurna | Selected unstructured data and context for AI | Long-term opportunity without proven material monetization |
| Rubrik Flex | One contract and commitment across products | Easier adoption and expansion |
Management describes four RAC pillars: observability, identity, runtime security and rewind. SAGE assesses action intent against rules. Reversing actions depends on supported systems and operations; “rewind” is not a universal guarantee of undoing every consequence.
Sources: Q2 FY2027 transcript and Goldman Sachs, September 10, 2026.
Competitive Advantages
Recovery expertise. Rubrik must identify problems and correctly restore data, permissions and application relationships. Management cites historical data, metadata and knowledge of real configurations as advantages. Recovery outcomes and sales success must establish the lead. Goldman Sachs, September 10
Switching costs. Replacing critical recovery systems requires integration, testing, migration and operating risk. Expansion supports infrastructure embeddedness, but NRR combines growth and departures and does not prove zero churn. Q2 transcript
Connected products. Shared data and identities can improve attack-scope visibility and recovery. Analyst Day showed over 70% of new customers starting in multiple categories. This supports the platform thesis through product synergies and switching costs; management's “network effects” should not automatically be read as cross-customer network effects. Analyst Day
Customer access. Relationships and a common sales organization aid Identity and RAC distribution, but competitiveness must be proven again in new categories.
Moat assessment: relatively strong in data recovery, emerging in Identity, unproven long term in RAC. Competitors can improve products or offer cheaper bundles.
Growth Drivers
- Legacy replacement: ransomware recovery and consistent multi-environment protection encourage switching.
- Existing-customer expansion: more data, applications and products drive measurable ARR and NRR.
- Identity Resilience: exceeded USD 50 million ARR in Q1, +38% sequentially. Attached Q2 results provide no new standalone Identity ARR; this milestone belongs to Q1.
- International and sovereign environments: Q2 revenue outside Americas +52%. Self-hosted and Private Edition address regulated customers and residency requirements.
- RAC and Annapurna: production-agent growth could add opportunities. Paid contracts, standalone ARR and economics must establish materiality. The October 9, 2026 Project Hourglass expansion adds AHEAD, Trace3 and WWT and includes Code Guardian. It remains in private preview; the announcement does not yet justify higher growth or margin assumptions.
Sources: attached Q1 transcript, Q2 transcript, Goldman Sachs.
Thesis priority: core data protection and cross-selling → Identity → RAC → Annapurna. Large TAM estimates do not replace orders and cash flow.
Economics & Financial Profile
Amounts in USD; fiscal quarters. Subscription ARR contribution margins are trailing 12-month figures.
| Metric | Q1 FY2027 | Q2 FY2027 |
|---|---|---|
| Subscription ARR | Roughly 1.57 billion | 1.66 billion |
| Year-over-year ARR growth | 32% | 33% |
| Net new subscription ARR | 103 million | Roughly 96 million |
| Revenue | 387.1 million | 427.3 million |
| Subscription revenue | 374.2 million | 407.2 million |
| Non-GAAP gross margin | 82.9% | 81.0% |
| Subscription ARR contribution margin | 13.2% | 14.0% |
| Free cash flow | Roughly 74 million | 65.7 million |
| Customers with at least USD 100,000 ARR | 2,946 | 3,084 |
Sources: attached transcripts; checked against Q1 results and Q2 results.
Updated FY2027 guidance: ARR USD 1.880–1.885 billion, revenue USD 1.685–1.693 billion, contribution margin around 15.5% and FCF USD 323–333 million. Management guidance, not a completed result. Q2 transcript
Earnings quality: Q2 GAAP net loss USD 61.8 million and stock compensation USD 101.0 million, roughly 24% of revenue. Positive FCF is not cash earnings without shareholder economic costs. 10-Q
Cash alongside dilution: Rubrik moved to net share settlement in Q2. During the first half it paid USD 53.278 million in taxes related to stock-award settlement; these payments are financing cash flows and are not deducted from reported FCF. Assessing shareholder cash therefore requires considering FCF, actual outflows and net share issuance together. This clarification concerns an existing economic weakness, rather than a new event after October 7. 10-Q, cash flow and RSU note
ARR contribution margin is neither GAAP nor non-GAAP revenue operating margin. Billing duration and prepayments affect FCF; shorter billing can constrain cash generation. Capture awards consistently through economic costs or dilution, without double-counting.
Management's long-term model: non-GAAP gross margin 77–82%, operating margin above 20%, FCF margin above 25% and low-single-digit dilution, over roughly 3–5 years. These remain targets. Source: attached transcript and Analyst Day.
Key KPIs
| KPI | Baseline | Interpretation |
|---|---|---|
| Subscription ARR and growth | USD 1.66 billion; +33% | Main subscription-growth measure |
| Net new subscription ARR | Roughly USD 96 million; +35% year over year | Early demand signal; compare seasonally matching quarters |
| Adjusted net new Cloud ARR | Q2 +20% year over year | Removes hosted-product migration effects |
| Average subscription NRR | Above 119% | Cohort expansion; four-quarter average can lag |
| Large customers | 3,084 above USD 100,000 ARR; +23% | Enterprise penetration |
| Identity ARR | Q1 above USD 50 million | Needs another standalone milestone |
| RAC | Q2 over 15 paying customers | Contract size and ARR matter beyond counts |
| FCF per share and dilution | FY2027 FCF guidance USD 323–333 million | Owner-value test |
Sources: attached transcripts; NRR definition in 10-Q.
Warning combination: declining net new ARR, weaker expansion and persistently high dilution. One weak quarter warrants scrutiny; several deteriorating measures change the thesis.
Management & Capital Allocation
Co-founder Bipul Sinha is CEO and chairman; co-founder Arvind Nithrakashyap CTO; Anneka Gupta leads product and Kiran Choudary finance. At Analyst Day, Jesse Green described eight and a half years at MongoDB and leading Rubrik Americas before becoming CRO.
Credibility to date: results and raised guidance. Between Q1 and Q2, ARR guidance midpoint rose from USD 1.858 to USD 1.8825 billion and FCF from USD 298 to USD 328 million. Management reported its tenth consecutive beat across guided metrics since IPO; the last two compared quarters support the claim. Source: attached transcripts.
Capital: product development and distribution take priority. Predibase added AI capabilities; Strata Identity added orchestration. The CFO explicitly reported zero Strata ARR contribution to Q2 or guidance, so this acquisition does not explain Q2 growth. Q2 transcript
Monitor: acquisition returns, talent costs and lower dilution. CEO vision does not guarantee an entire new market; assess AI superlatives against customer outcomes and monetization.
Risks / Bear Case
| Risk | Stock-value mechanism |
|---|---|
| Multiple compression | Growth may not offset normalization of an exceptional premium |
| Weaker net new ARR | Total growth eventually slows despite good reported revenue |
| Competition and bundles | Commvault, Veeam, Cohesity and native cloud solutions pressure pricing or win rates |
| AI and Identity rivals | Security, identity and cloud platforms capture budgets |
| Weaker AI-product economics | Inference, implementation and support costs outrun monetization |
| Stock awards | Dilution and cash for net share settlement weaken per-share value; financing outflows are absent from reported FCF |
| Recovery failure or security incident | Severe trust damage given critical product role |
| Slower agent adoption | RAC and Annapurna remain small longer than optimistic assumptions |
Competitive context comes from attached Analyst Day/conference materials; effects are analytical scenarios.
Bear case: growth continues but slows toward 18%, AI adds little and valuation falls. Investors can lose without operational collapse.
Counterweight to the CEO narrative: recovery complements prevention and detection. Claims that AI attacks make detection “impossible” are management interpretation, not proof that other security layers lose value. Goldman Sachs
Valuation
ChatGPT produces the calculations and valuation scenarios. Share-price inputs are dated to the analysis; they are not continuously updated market data.
Different outcomes. Different values.
122.51 USD · October 12, 2026 · intraday 10:43 a.m. EDT
The USD 122.51 reference price is an intraday quote from October 12, 2026 at 10:43 a.m. EDT (4:43 p.m. Czech time). RBRK, Class A shares, NYSE, USD. Assessed October 12, 2026. History and quote — StockAnalysis. The market was open at the quote time; this is not a closing price. The last verified closing price remains USD 125.14 on October 9, 2026 at 4:00 p.m. EDT.
Using 207.304433 million outstanding Class A and B shares from the latest 10-Q cover gives indicative market capitalization of USD 25.40 billion. Cash and short-term investments of USD 1.747649 billion less nominal convertible debt of USD 1.150 billion imply roughly USD 0.598 billion net cash. Indicative EV is USD 24.80 billion. Shares are dated August 24, 2026, the balance sheet July 31, 2026 and intraday quote October 12, 2026 at 10:43 a.m. EDT; the calculation combines different reference dates. July 31, 2026 10-Q
| Indicative multiple | Value | Basis |
|---|---|---|
| EV / FY2027 revenue | 14.7× | Revenue guidance midpoint USD 1.689 billion |
| EV / FY2027 ending ARR | 13.2× | ARR guidance midpoint USD 1.8825 billion |
| FY2027 FCF / market capitalization | 1.29% | FCF guidance midpoint USD 328 million |
| EV / revenue using 230 million-share proxy | 16.3× | Sensitivity to a broader share base |
Calculations use guidance from the Q2 FY2027 transcript. ARR is not revenue; multiples of these quantities cannot be interchanged directly. The 230 million figure derives from Q3 non-GAAP guidance and is only a more conservative modeling proxy, not an exact current fully diluted cap table.
Price Attractiveness
Price attractiveness: 3.0/10 at USD 122.51; quote dated October 12, 2026, 10:43 a.m. EDT (intraday), assessed October 12, 2026. Horizon: three years to October 12, 2029. Methodology: Assessment methodology.
Valuation at October 12, 2029 uses expected full-year FY2030 revenue; that fiscal year ends January 31, 2030. This is a multiple of expected full-year revenue for the fiscal year then in progress, rather than moving the price horizon to January 2030. Three fiscal growth steps from the FY2027 guidance midpoint of USD 1.689 billion lead to FY2030 revenue. We retain the base and bear growth and multiple assumptions; the new product is not yet separately monetized in the model. The economic growth and multiple assumptions in the base and bear cases are retained; the new product is not yet separately monetized in the model.
| Item | Base case | Bear case |
|---|---|---|
| Business assumptions | Revenue grows 25% annually; effective cross-selling and higher margins, without requiring major Code Guardian ARR | Growth slows to 18%; competition limits expansion, AI products remain small and operating leverage weakens |
| Margins — analytical assumptions supporting the multiple | FCF margin around 25%, monitoring cash settlement and dilution | FCF margin around 18%; higher costs and weaker shareholder economics |
| FY2030 revenue | USD 3.299 billion | USD 2.775 billion |
| Future valuation at October 12, 2029 | 9× EV / expected full-year FY2030 revenue | 6× EV / expected full-year FY2030 revenue |
| Share base — modeling proxy | 230 million × 1.03³ = 251.33 million | 230 million × 1.04³ = 258.72 million |
| Net cash after nominal debt | USD 1.6 billion | USD 1.0 billion |
| Price in three years | USD 124.50 | USD 68.22 |
| Three-year dividends | USD 0, model assumption | USD 0, model assumption |
| Total three-year return versus USD 122.51 | +1.6% | −44.3% |
Core relationship: share value = (revenue × EV multiple + net cash) / modeled share count. Growth, margins, multiples, future cash, dividends and dilution are our assumptions, not company guidance or consensus. Margins explain the economic justification for multiples; they are not a second simultaneous price calculation.
230 million is a conservative analytical proxy inspired by Q3 non-GAAP guidance, rather than an exact current cap table. We use it here for stock awards and options; we do not add the full debt-conversion share count again. Nominal debt is deducted once in net cash, and we make no further SBC deduction from the resulting price. Future net cash should already reflect award cash settlement; we do not mechanically extrapolate reported FCF into owner cash. Above the USD 175.10 capped-call limit, conversion and settlement would need reassessment. Returns are before taxes, fees and USD/CZK effects, without dividend reinvestment.
Reading the scenarios: even the base assumes strong growth and a premium 9× revenue multiple. Nevertheless, the reference price offers almost no nominal appreciation. Future USD 124.50 is not worth the same as USD 124.50 today; at a 10% annual required return, its present value is approximately USD 93.54. This is the discounted value of one scenario, rather than an independently determined intrinsic value.
- Brief rationale: at the USD 122.51 intraday quote, the three-year base return is approximately +1.6%, adverse −44.3%. The price is 2.1% below the October 9 close, but this small movement still provides insufficient risk compensation. Attractiveness therefore stays at 3.0/10; economic assumptions and scenario prices are unchanged.
- Main weakness: results are sensitive to growth durability, a high terminal multiple and actual per-share value after stock awards and cash settlement.
- Assessment confidence: Medium. Price and starting results are verified; three-year margins, dilution and multiples remain uncertain.
- Condition for change: a lower price with the same thesis or demonstrated higher FCF per share would improve the rating. For example, at USD 95 the same cases imply roughly +31% / −28%; this is analytical sensitivity, not an automatic buy instruction. Weaker ARR/NRR or larger outflows and dilution would worsen them.
- Main sources: Intraday price — October 12, 2026 at 10:43 a.m. EDT, Q2 FY2027 results released August 27, 2026, period through July 31, 2026 and July 31, 2026 10-Q.
What Would Change the Assessment?
These are my monitoring rules, not company guidance.
| Observation | Thesis impact |
|---|---|
| ARR growth below 20% and weak net new ARR for two consecutive quarters | Reassess growth durability |
| NRR heading below 110% | Check cross-selling, departures and pricing; allow for averaging lag |
| Worse win rates or repeated price concessions | Lower moat confidence |
| FCF grows but per-share FCF stagnates through dilution | Weaker shareholder economics |
| Major recovery failure at a key customer | Reassess technical credibility and reputation |
| Further major standalone Identity ARR milestones | More confidence in the second engine |
| Material paid RAC ARR, expansion and sustainable margins | Justified higher growth assumptions |
| FCF margin moving above 25% with low dilution | Stronger per-share value evidence |
Slower RAC alone need not destroy data-protection/Identity theses, but can seriously weaken exceptional-valuation justification.
Current View
As of October 12, 2026, the operating thesis is strong. Rubrik grows at scale, customers expand platform usage and Identity has tangible traction. AI-agent security may add another growth layer, but its scale and economics remain to be proven. The new Hourglass announcement supports distribution; without reported monetization it does not change the main operating conclusion. The October 9, 2026 Hourglass announcement supports distribution, but without reported monetization it does not change the core operating conclusion.
Research stance on the stock: valuation requires caution and further evidence. The USD 122.51 reference intraday quote offers no persuasive return in the stated base case. Without greater long-term potential or a lower price, an attractive risk–return balance is difficult to justify. High price independently warrants caution even with a healthy business.
Next review: upcoming results should confirm net new ARR, customer expansion and cash flow per share. For Identity and RAC, new paid ARR milestones carry more weight than further expansion of the product narrative. No next-earnings date is assumed here.
Business strength
Business strength: 7.8/10. Assessed: October 12, 2026. Methodology: Assessment methodology. The five components are unchanged from October 10: no new operating evidence supporting a score change was found in available materials. Decimal reporting under the current methodology does not signify greater confidence or a changed business thesis.
| Area | Score | Main evidence |
|---|---|---|
| Competitive advantage | 8.0/10 | Q2 FY2027: 3,084 customers above USD 100,000 ARR and NRR above 119%. Critical integrations support switching costs; examples of wins are management claims. RAC’s moat remains unproven. |
| Demand durability | 9.0/10 | Recurring operational-recovery subscriptions; ARR grew 32% in Q1 and 33% in Q2 FY2027. Data-recovery demand persists despite changes in attack types. |
| Management execution | 8.0/10 | Q1 and Q2 FY2027 beat guided metrics and increased guidance; Q2 net new ARR grew 35% YoY. Evidence is execution, not the strength of the AI narrative. |
| Business economics | 6.0/10 | Q2: non-GAAP gross margin 81%, FCF USD 65.7 million; alongside GAAP loss USD 61.8 million, SBC USD 101.0 million and cash settlement outside FCF. Per-share value needs further proof. |
| Financial resilience | 8.0/10 | July 31, 2026 liquid assets USD 1.748 billion versus USD 1.15 billion nominal convertible debt; maturity June 15, 2030 and positive FCF. Awards and future conversion remain risks. |
Calculation: (8.0 + 9.0 + 8.0 + 6.0 + 8.0) / 5 = 7.8. Each area has 20% weight; price and stock ownership do not enter the score.
- Brief rationale: Rubrik has a strong position in critical operational recovery, recurring demand and demonstrated execution across multiple quarters. Shareholder economics after awards constrain the average. Hourglass and Code Guardian are opportunities; a private-preview announcement alone does not justify a higher score.
- Main weakness: the gap between ARR growth and reported FCF on one side, and cash and per-share value after SBC, dilution and net share settlement on the other.
- Assessment confidence: Medium. Results and filings are available; moat durability and economics in new categories have less evidence.
- Condition for change: higher actual cash generation per share with low dilution, and material paid ARR/expansion in Identity and RAC, could raise the score. Two quarters of ARR growth below 20%, weakening NRR or demonstrated recovery failure would require reductions in the affected areas.
- Main sources: Q1 FY2027, June 4, 2026, period through April 30, 2026; Q2 FY2027, August 27, 2026, period through July 31, 2026; Q2 transcript; July 31, 2026 10-Q; Goldman Sachs, September 10, 2026; Hourglass, October 9, 2026.
Thesis History / Updates
| Event date | Change or new evidence | Impact |
|---|---|---|
| June 4, 2026 | Q1 FY2027: ARR around USD 1.57 billion; Identity above USD 50 million; higher guidance | Supports core growth and Identity |
| June 10, 2026 | Analyst Day: multiproduct adoption, Rubrik Flex and long-term margin targets | Clearer platform economics; long-term targets remain conditional |
| August 27, 2026 | Q2 FY2027: ARR USD 1.66 billion; net new ARR acceleration; more than 15 paying RAC customers | Stronger operating evidence and initial RAC commercial traction |
| September 10, 2026 | Goldman Sachs: confirms data, identity and agent strategy; Annapurna described as very early | Strategic continuity without new financial guidance |
| October 7, 2026 | Initial investment card; valuation added using October 6 price | Thesis intact; expected return sensitive to price and multiple |
| October 9, 2026 | Hourglass expanded with AHEAD, Trace3, WWT and Code Guardian in private preview | Distribution/product opportunity; without new ARR/revenue we do not raise model assumptions |
| October 10, 2026 | Price, SEC and source review; first two scores under methodology 1.0; cash settlement added | Operating thesis intact; price still poorly compensates for risk; project review partial |
| October 12, 2026 | Current methodology 1.1 applied; repriced at intraday USD 122.51; review of available new evidence | Business strength 7.8/10 and attractiveness 3.0/10 unchanged; scenarios +1.6% / −44.3%; evidence coverage remains partial |
Rating history
| Assessment date | Methodology | Business strength | Price Attractiveness and quote | Reason |
|---|---|---|---|---|
| October 7, 2026 | Numeric scores under 1.0 not provided | Not numerically assessed | Historical qualitative valuation at USD 125.80, October 6, 2026 close | Original FY2030 illustration had a longer horizon around 3.3 years; not a comparable score. Base around USD 125, weaker development USD 68, strong execution around USD 199. |
| October 10, 2026 | 1.0 | 7.8/10 | 3/10 at USD 125.14, October 9, 2026 close | First standardized assessment; new product announcement does not change conclusions; price horizon standardized at three years. |
| October 12, 2026 | 1.1 | 7.8/10 | 3.0/10 at USD 122.51, October 12, 2026 intraday quote at 10:43 a.m. EDT | Numerical values preserved under decimal reporting; price recalculated. Conclusions and economic assumptions unchanged. Methodology 1.0 history retains its original reporting. |
Sources
- Attached RBRK_1Q2026.txt: Q1 FY2027. Official June 4, 2026 results.
- Attached Rubrick-Analyst-Day-11.6.2026.txt: the event in the transcript header is June 10, 2026. June 10, 2026 Analyst Day.
- Q2 FY2027 transcript: period ending July 31, 2026, published August 27, 2026. Official results.
- Goldman Sachs, September 10, 2026: CEO commentary on strategy and competitive position.
- July 31, 2026 10-Q: shares, stock awards, GAAP results, convertible debt and NRR definition.
- Historical RBRK price: October 6, 2026 closing price USD 125.80.
- Current price input — StockAnalysis: intraday USD 122.51 on October 12, 2026 at 10:43 a.m. EDT, used for the October 12 assessment. The last verified October 9, 2026 close is USD 125.14.
- Official Hourglass announcement, October 9, 2026: new partners and Code Guardian in private preview.
Evidence distinctions: results and guidance are supported by transcripts and company materials. Technology leadership and some competitive claims are management views. Moat assessment, monitoring thresholds and valuation scenarios are analytical judgments. Prices and scenarios apply as of the stated date.
Analytical limitation: The assessment rests mainly on Q2 FY2027 results and the latest available transcripts. Coverage of newer announcements is incomplete and older Q1/Analyst Day materials were not fully reassessed in this update. This limits confidence in broader evidence coverage; original growth assumptions are unchanged. The reference price is intraday, not the October 12 close.
Was this analysis useful to you?